Time-Resolved Contrast-Enhanced Three-Dimensional Pulmonary MR-Angiography: 1.0 M Gadobutrol vs. 0.5 M Gadopentetate Dimeglumine

Journal of Magnetic Resonance Imaging

Volumn 19, Issue 2, 2004, Pages 202-208

  Fink, Christian ^a   Bock, Michael ^a   Kiessling, Fabian ^a   Lichy, Matthias Philipp ^a   Krissak, Radko ^a   Zuna, Ivan ^a   Schmähl, Astrid ^b   Delorme, Stefan ^a   Kauczor, Hans Ulrich ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b Thoraxklinik ^*  (Germany)

Author keywords

Comparative study; Contrast agent; Lung; Magnetic resonance angiography; Time resolved

Indexed keywords

GADOBUTROL; GADOLINIUM PENTETATE; GADOLINIUM PENTETATE MEGLUMINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTRAST ENHANCEMENT; CONTRAST TO NOISE RATIO; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG INJECTION RATE; DRUG INJECTION VOLUME; FEMALE; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; INTERMETHOD COMPARISON; LUNG ARTERY; LUNG VEIN; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIGNAL NOISE RATIO; THREE DIMENSIONAL IMAGING; THREE DIMENSIONAL PULMONARY MAGNETIC RESONANCE ANGIOGRAPHY;

ADULT; AGED; CONTRAST MEDIA; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GADOLINIUM DTPA; HUMANS; IMAGING, THREE-DIMENSIONAL; INJECTIONS, INTRAVENOUS; LUNG DISEASES; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; PULMONARY ARTERY; PULMONARY CIRCULATION; PULMONARY VEINS; REFERENCE VALUES; STATISTICS, NONPARAMETRIC; TIME FACTORS;

EID: 0842347721     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmri.10452     Document Type: Article

References (24)

1. Meaney JF, Johansson LO, Ahlstrom H, Prince MR. Pulmonary magnetic resonance angiography. J Magn Reson Imaging 1999;10: 326-338.
2. Oudkerk M, van Beek EJ, Wielopolski P, et al. Comparison of contrast-enhanced magnetic resonance angiography and conventional pulmonary angiography for the diagnosis of pulmonary embolism: a prospective study. Lancet 2002;359:1643-1647.
3. Wielopolski PA, Haacke EM, Adler LP. Three-dimensional MR imaging of the pulmonary vasculature: preliminary experience. Radiology 1992;183:465-472.
4. Wielopolski PA. Magnetic resonance pulmonary angiography. Coron Artery Dis 1999;10:157-175.
5. Vrachliotis TG, Bis KG, Kirsch MJ, Shetty AN. Contrast-enhanced MRA in pre-embolization assessment of a pulmonary arteriovenous malformation. J Magn Reson Imaging 1997;7:434-436.
6. Mohrs OK, Voigtlander T, Heussel CP, Bardeleben S, Duber C, Kreitner KF. Morphologic and functional assessment of vascular abnormalities of the pulmonary vasculature by breath-hold MR techniques. Röfo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 2002;174:467-473
7. Abolmaali ND, Hietschold V, Appold S, Ebert W, Vogl TJ. Gadomer-17-enhanced 3D navigator-echo MR angiography of the pulmonary arteries in pigs. Eur Radiol 2002;12:692-697.
8. Fink C, Eichhorn J, Bock M. Pulmonary arteriovenous malformation and aortopulmonary collateral imaged by time resolved contrast enhanced magnetic resonance angiography. Heart 2002;88: 292.
9. Goyen M, Laub G, Ladd ME, et al. Dynamic 3D MR angiography of the pulmonary arteries in under four seconds. J Magn Reson Imaging 2001;13:372-377.
10. Schoenberg SO, Bock M, Floemer F, et al. High-resolution pulmonary arterio- and venography using multiple-bolus multiphase 3D-Gd-mRA. J Magn Reson Imaging 1999;10:339-346.
11. Bock M, Schoenberg SO, Floemer F, Schad LR. Separation of arteries and veins in 3D MR angiography using correlation analysis. Magn Reson Med 2000;43:481-487.
12. Ohno Y, Kawamitsu H, Higashino T, et al. Time-resolved contrast-enhanced pulmonary MR angiography using sensitivity encoding (SENSE). J Magn Reson Imaging 2003;17:330-336.
13. Tombach B, Heindel W. Value of 1.0-M gadolinium chelates: review of preclinical and clinical data on gadobutrol. Eur Radiol 2002;12: 1550-1556.
14. Volk M, Strotzer M, Lenhart M, et al. Renal time-resolved MR angiography: quantitative comparison of gadobenate dimeglumine and gadopentetate dimeglumine with different doses. Radiology 2001;220:484-488.
15. Goyen M, Lauenstein TC, Herborn CU, Debatin JF, Bosk S, Ruehm SG. 0.5 M Gd chelate (Magnevist) versus 1.0 M Gd chelate (Gadovist): dose-independent effect on image quality of pelvic three-dimensional MR-angiography. J Magn Reson Imaging 2001;14: 602-607.
16. Herborn CU, Lauenstein TC, Ruehm SG, Bosk S, Debatin JF, Goyen M. Intraindividual comparison of gadopentetate dimeglumine, gadobenate dimeglumine, and gadobutrol for pelvic 3D magnetic resonance angiography. Invest Radiol 2003;38:27-33.
17. Von Tengg-Kobligk H, Floemer F, Knopp MV. Multiphasic MR angiography as an intra-individual comparison between the contrast agents Gd-DTPA, Gd-BOPTA, and Gd-BT-DO3A. Radiologe 2003; 43:171-178.
18. Staks T, Schuhmann-Giampieri G, Frenzel T, Weinmann HJ, Lange L, Platzek J. Pharmacokinetics, dose proportionality, and tolerability of gadobutrol after single intravenous injection in healthy volunteers. Invest Radiol 1994;29:709-715.
19. Vogler H, Platzek J, Schuhmann-Giampieri G, et al. Pre-clinical evaluation of gadobutrol: a new, neutral, extracellular contrast agent for magnetic resonance imaging. Eur J Radiol 1995;21:1-10.
20. Tombach B, Bremer C, Reimer P, et al. Renal tolerance of a neutral gadolinium chelate (gadobutrol) in patients with chronic renal failure: results of a randomized study. Radiology 2001;218:651-657.
21. Hany TF, Schmidt M, Hilfiker PR, Steiner P, Bachmann U, Debatin JF. Optimization of contrast dosage for gadolinium-enhanced 3D MRA of the pulmonary and renal arteries. Magn Reson Imaging 1998;16:901-906.
22. Gudbjartsson H, Patz S. The Rician distribution of noisy MRI data. Magn Reson Med 1995;34:910-914.
23. Altmann DG. Practical statistics for medical research. London: Chapman & Hall: 1991.
24. Korosec FR, Frayne R, Grist TM, Mistretta CA. Time-resolved contrast-enhanced 3D MR angiography. Magn Reson Med 1996;36: 345-351.